azathioprine has been researched along with Graft-Versus-Host Disease in 42 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three cases of nodular regenerative hyperplasia of the liver associated with azathioprine therapy are reported." | 8.78 | [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. ( Dhumeaux, D; Duvoux, C; Kracht, M; Lang, P; Vernant, JP; Zafrani, ES, 1991) |
| "This paper presents the first report of the use of topical azathioprine in the management of persistent symptomatic chronic oral graft-versus-host disease (GVHD)." | 7.70 | Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. ( Epstein, JB; Nantel, S; Sheoltch, SM, 2000) |
| "Treatment with prednisone alone results in fewer infections and better survival than prednisone and azathioprine in standard-risk chronic GVHD." | 6.66 | Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. ( Appelbaum, FR; Dahlberg, S; Deeg, HJ; Doney, KC; Flournoy, N; Sanders, JE; Storb, R; Sullivan, KM; Weiden, P; Witherspoon, RP, 1988) |
| "Three cases of nodular regenerative hyperplasia of the liver associated with azathioprine therapy are reported." | 4.78 | [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. ( Dhumeaux, D; Duvoux, C; Kracht, M; Lang, P; Vernant, JP; Zafrani, ES, 1991) |
| "This paper presents the first report of the use of topical azathioprine in the management of persistent symptomatic chronic oral graft-versus-host disease (GVHD)." | 3.70 | Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. ( Epstein, JB; Nantel, S; Sheoltch, SM, 2000) |
| "Treatment with prednisone alone results in fewer infections and better survival than prednisone and azathioprine in standard-risk chronic GVHD." | 2.66 | Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. ( Appelbaum, FR; Dahlberg, S; Deeg, HJ; Doney, KC; Flournoy, N; Sanders, JE; Storb, R; Sullivan, KM; Weiden, P; Witherspoon, RP, 1988) |
| "The renal biopsy showed type I membranoproliferative glomerulonephritis." | 1.36 | Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation. ( Chang, YS; Chung, S; Kim, B; Kim, JY; Lee, MY; Park, CW, 2010) |
| "A 26-year-old male with acute lymphoblastic leukemia (ALL) in its second complete remission received an unrelated bone marrow transplantation (UBMT) following cyclophosphamide plus total body irradiation conditioning." | 1.31 | A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. ( Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A, 2002) |
| " The lower variability of trough levels and the higher L/D ratio in the CyE group, which are related ti improved bioavailability of CyE, may explain the lower rejection rate among these patients." | 1.30 | Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation. ( Haberal, M; Karakayali, H; Moray, G; Senel, FM; Yildirim, S, 1997) |
| " Throughout the dosing interval, the enzyme activities parallel the respective drug concentrations." | 1.30 | Pharmacodynamic monitoring of immunosuppressive drugs. ( Aspeslet, LJ; Gallant, HL; Yatscoff, RW, 1998) |
| "Detection of the chronic myelogenous leukemia (CML)-related marker, the bcr/abl m-RNA transcript, in blood or bone marrow of patients with CML in hematologic remission after allogeneic bone marrow transplantation (allo-BMT) may be associated with the presence of minimal residual disease but does not uniformly predict hematologic relapse." | 1.29 | Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation. ( Agaliotis, DP; Elfenbein, GJ; Moscinski, LC; Papenhausen, PR, 1995) |
| "Thalidomide treatment was successful in the majority of animals (16 of 18)." | 1.28 | Therapy of chronic graft-v-host disease in a rat model. ( Friedman, KJ; Hess, AD; Santos, GW; Vogelsang, GB, 1989) |
| " Although one patient subsequently required chronic dialysis, reduction of cyclosporine dosage from a mean of 5." | 1.27 | Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. ( Bahnson, HT; Bernstein, RL; Egel, JW; Greenberg, A; Griffith, BP; Hardesty, RL; Hastillo, A; Hess, ML; Puschett, JB; Thompson, ME, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (47.62) | 18.7374 |
| 1990's | 9 (21.43) | 18.2507 |
| 2000's | 9 (21.43) | 29.6817 |
| 2010's | 4 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uhm, J | 1 |
| Shin, E | 1 |
| Michelis, FV | 1 |
| Thyagu, S | 1 |
| Viswabandya, A | 1 |
| Lipton, JH | 2 |
| Messner, HA | 2 |
| Kim, DDH | 1 |
| Chien, SH | 1 |
| Liu, CJ | 1 |
| Hong, YC | 1 |
| Teng, CJ | 1 |
| Hu, YW | 1 |
| Shen, CC | 1 |
| Ku, FC | 1 |
| Chen, SC | 1 |
| Yeh, CM | 1 |
| Chiou, TJ | 1 |
| Gau, JP | 1 |
| Tzeng, CH | 1 |
| Fix, OK | 1 |
| Stock, PG | 1 |
| Lee, BK | 1 |
| Benson, MD | 1 |
| Kim, JY | 1 |
| Lee, MY | 1 |
| Kim, B | 1 |
| Park, CW | 1 |
| Chang, YS | 1 |
| Chung, S | 1 |
| Uehara, T | 1 |
| Nakaseko, C | 1 |
| Yokota, A | 1 |
| Saito, Y | 1 |
| Nishimura, M | 1 |
| Sasaki, M | 1 |
| Fujiyama, Y | 1 |
| Gaziev, J | 1 |
| Sodani, P | 1 |
| Polchi, P | 1 |
| Andreani, M | 1 |
| Lucarelli, G | 1 |
| Lin, PC | 1 |
| Hsiao, LT | 1 |
| Chen, PM | 1 |
| Habib, S | 1 |
| Nalesnik, MA | 1 |
| Ahmad, J | 1 |
| BuchBarker, D | 1 |
| Shakil, AO | 1 |
| Reményi, P | 1 |
| Masszi, T | 1 |
| Borbényi, Z | 1 |
| Soós, J | 1 |
| Siklós, L | 1 |
| Engelhardt, JI | 1 |
| Castro, LA | 1 |
| Eigler, J | 1 |
| Land, W | 1 |
| Cohen, DJ | 1 |
| Loertscher, R | 1 |
| Rubin, MF | 1 |
| Tilney, NL | 1 |
| Carpenter, CB | 1 |
| Strom, TB | 1 |
| Tampi, R | 1 |
| Barr, AL | 1 |
| Zilko, PJ | 1 |
| Kanamaru, A | 1 |
| Takemoto, Y | 1 |
| Kakishita, E | 1 |
| Dohy, H | 1 |
| Kodera, Y | 1 |
| Moriyama, Y | 1 |
| Shibata, A | 1 |
| Kasai, M | 1 |
| Katoh, S | 1 |
| Saitoh, H | 1 |
| Agaliotis, DP | 1 |
| Papenhausen, PR | 1 |
| Moscinski, LC | 1 |
| Elfenbein, GJ | 1 |
| Adams, GB | 1 |
| Jamal, N | 1 |
| Yaron, I | 1 |
| Yaron, R | 1 |
| Oluwole, SF | 1 |
| Hardy, MA | 1 |
| Gruessner, RW | 1 |
| Fasola, C | 1 |
| Fryer, J | 1 |
| Nakhleh, RE | 1 |
| Kim, S | 1 |
| Gruessner, AC | 1 |
| Beebe, D | 1 |
| Moon, C | 1 |
| Troppmann, C | 1 |
| Najarian, JS | 1 |
| Senel, FM | 1 |
| Yildirim, S | 1 |
| Karakayali, H | 1 |
| Moray, G | 1 |
| Haberal, M | 1 |
| Yatscoff, RW | 1 |
| Aspeslet, LJ | 1 |
| Gallant, HL | 1 |
| Epstein, JB | 2 |
| Nantel, S | 2 |
| Sheoltch, SM | 1 |
| Gorsky, M | 1 |
| Epstein, MS | 1 |
| Maury, S | 1 |
| Mary, JY | 1 |
| Rabian, C | 1 |
| Schwarzinger, M | 1 |
| Toubert, A | 1 |
| Scieux, C | 1 |
| Carmagnat, M | 1 |
| Esperou, H | 1 |
| Ribaud, P | 1 |
| Devergie, A | 1 |
| Guardiola, P | 1 |
| Vexiau, P | 1 |
| Charron, D | 1 |
| Gluckman, E | 1 |
| Socié, G | 1 |
| Alsina, AE | 1 |
| Nagashima, I | 1 |
| Schweizer, RT | 1 |
| Duvoux, C | 1 |
| Kracht, M | 1 |
| Lang, P | 1 |
| Vernant, JP | 2 |
| Zafrani, ES | 1 |
| Dhumeaux, D | 1 |
| Appleby, P | 1 |
| Webber, DG | 1 |
| Bowen, JG | 1 |
| Wingard, JR | 1 |
| Piantadosi, S | 1 |
| Vogelsang, GB | 2 |
| Farmer, ER | 1 |
| Jabs, DA | 1 |
| Levin, LS | 1 |
| Beschorner, WE | 1 |
| Cahill, RA | 1 |
| Miller, DF | 1 |
| Harrison, D | 1 |
| Sullivan, KM | 2 |
| Buckner, CD | 1 |
| Sanders, JE | 2 |
| Anasetti, C | 1 |
| Appelbaum, FR | 2 |
| Clark, J | 1 |
| Doney, K | 1 |
| Meyers, J | 1 |
| Sale, G | 1 |
| Storb, R | 2 |
| Hess, AD | 1 |
| Friedman, KJ | 1 |
| Santos, GW | 1 |
| Witherspoon, RP | 1 |
| Weiden, P | 1 |
| Flournoy, N | 1 |
| Dahlberg, S | 1 |
| Deeg, HJ | 1 |
| Doney, KC | 1 |
| Marit, G | 1 |
| Maraninchi, D | 1 |
| Guyotat, D | 1 |
| Kuentz, M | 1 |
| Cordonnier, C | 1 |
| Reiffers, J | 1 |
| Greenberg, A | 1 |
| Egel, JW | 1 |
| Thompson, ME | 1 |
| Hardesty, RL | 1 |
| Griffith, BP | 1 |
| Bahnson, HT | 1 |
| Bernstein, RL | 1 |
| Hastillo, A | 1 |
| Hess, ML | 1 |
| Puschett, JB | 1 |
| First, LR | 1 |
| Smith, BR | 1 |
| Lipton, J | 1 |
| Nathan, DG | 1 |
| Parkman, R | 1 |
| Rappeport, JM | 1 |
| Pichlmaier, H | 1 |
| Kline, TS | 1 |
| Craighead, JE | 1 |
| Häyry, P | 1 |
| Lalla, M | 1 |
| Pasternack, A | 1 |
| Virolainen, M | 1 |
| Husberg, B | 1 |
| Carlsson, S | 1 |
| Hellsten, S | 1 |
| Liedberg, CF | 1 |
| Nettelblad, SC | 1 |
| Weiber, A | 1 |
| Ota, K | 1 |
| Mori, S | 1 |
| Inou, T | 1 |
| Kanazawa, Y | 1 |
| Kuzuya, T | 1 |
| Kalter, SS | 1 |
| Ratner, IA | 1 |
| Britton, HA | 1 |
| Vice, TE | 1 |
| Eugster, AK | 1 |
| Rodriguez, AR | 1 |
| DeKlerk, JN | 1 |
| Murphy, GP | 1 |
| Van Zyl, JJ | 1 |
| Van Zyl, JA | 1 |
| Weber, HW | 1 |
| Brede, HD | 1 |
| Scott, WW | 1 |
| Levitt, SH | 1 |
| Royster, RL | 1 |
| O'Foughludha, FT | 1 |
| Wolf, JS | 1 |
| Lower, RR | 1 |
| King, ER | 1 |
| DeGiorgi, LS | 1 |
| Namba, T | 1 |
| Arimori, S | 1 |
| Grob, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of Belumosudil and Rituximab for the Primary Treatment of Extensive Chronic Graft-versus-host Disease[NCT06046248] | Phase 2 | 25 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
| Azacitidine (AZA) Combined With N-Acetyl-L-cysteine (NAC) for Prolonged Isolated Thrombocytopenia (PIT) After Hematopoietic Stem Cell Transplantation (HSCT)[NCT05126004] | Phase 2 | 100 participants (Anticipated) | Interventional | 2021-12-01 | Not yet recruiting | ||
| A Prospective Study of Patients With Isolated Thrombocytopenia Following Hematopoietic Stem Cell Transplantation[NCT02487563] | Phase 3 | 97 participants (Actual) | Interventional | 2015-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The total number of megakaryocytes as well as the platelet-shedding megakaryocytes of bone marrow smears (per cm2) was counted and cross-checked by blinded observers. (NCT02487563)
Timeframe: Up to 4 weeks after the treatment
| Intervention | cells/cm^2 (Median) |
|---|---|
| Experimental Group 1 | 6.7 |
| Experimental Group 2 | 7.5 |
| Control Group | 3.3 |
Platelet response refers to a sustained increase (stable or increasing level) of at least 30×10E9/L independent of transfusion for 3 days. (NCT02487563)
Timeframe: Up to 4 weeks after the treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| Experimental Group 1 | 20 |
| Experimental Group 2 | 22 |
| Control Group | 6 |
5 reviews available for azathioprine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
[Azathioprine].
Topics: Apoptosis; Azathioprine; CD28 Antigens; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combinatio | 2005 |
[After care of kidney transplant patients].
Topics: Adrenal Cortex Hormones; Aftercare; Antilymphocyte Serum; Azathioprine; Cyclosporins; Graft Rejectio | 1983 |
Cyclosporine: a new immunosuppressive agent for organ transplantation.
Topics: Animals; Azathioprine; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Cyclospo | 1984 |
[Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
Topics: Adult; Azathioprine; Graft vs Host Disease; Humans; Hyperplasia; Hypertension, Portal; Immunosuppres | 1991 |
Long-term complications of bone marrow transplantation.
Topics: Azathioprine; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Humans; Prednison | 1989 |
2 trials available for azathioprine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; | 1995 |
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disea | 1988 |
35 other studies available for azathioprine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
Topics: Adult; Aged; Azathioprine; Canada; Chronic Disease; Drug Therapy, Combination; Female; Graft vs Host | 2018 |
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.
Topics: Adult; Azathioprine; Cohort Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transpla | 2015 |
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosis.
Topics: Amyloidosis; Azathioprine; Creatinine; Female; Fibrinogen; Gene Expression; Genes, Dominant; Graft v | 2016 |
Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Azathioprine; Glomerulonephritis, Membranoproliferative; Graft vs Host Disease; Hematopoietic | 2010 |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Trans | 2002 |
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical | 2005 |
Acute graft-versus-host disease of the lung with atypical presentation.
Topics: Acute Disease; Anti-Inflammatory Agents; Azathioprine; Graft vs Host Disease; Hematopoietic Stem Cel | 2006 |
Alloimmune hepatitis following peripheral stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Busulfan; Cyclophosphamide; Female; Graft vs Host Dis | 2007 |
CIDP cured by allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Alopecia; Anemia, Aplastic; Azathioprine; Cyclophosphamide; Female; Graft vs Host Disease; He | 2007 |
Case report. Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine.
Topics: Adult; Azathioprine; Graft vs Host Disease; Humans; Male; Penicillamine; Prednisolone | 1984 |
Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.
Topics: Adult; Azathioprine; Blast Crisis; Bone Marrow Transplantation; Female; Graft vs Host Disease; Human | 1995 |
Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy.
Topics: Antineoplastic Agents; Azathioprine; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cy | 1994 |
UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Topics: Apoptosis; Azathioprine; Clonal Anergy; Cyclosporine; Cytotoxicity, Immunologic; DNA Damage; Graft v | 1996 |
Quadruple immunosuppression in a pig model of small bowel transplantation.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Graft R | 1996 |
Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation.
Topics: Azathioprine; Biological Availability; Cyclosporine; Drug Delivery Systems; Emulsions; Graft vs Host | 1997 |
Pharmacodynamic monitoring of immunosuppressive drugs.
Topics: Azathioprine; Calcineurin; Cyclosporine; Drug Monitoring; Graft vs Host Disease; Humans; Immunosuppr | 1998 |
Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
Topics: Administration, Topical; Adult; Anemia, Aplastic; Azathioprine; Bone Marrow Transplantation; Candidi | 2000 |
Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
Topics: Adult; Autoimmune Diseases; Azathioprine; Chronic Disease; Erythema; Female; Gels; Graft vs Host Dis | 2001 |
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.
Topics: Adolescent; Adult; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocyt | 2001 |
Orthotopic porcine small bowel transplantation using low-dose cyclosporine in triple immunosuppressive therapy.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Gra | 1992 |
Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.
Topics: Animals; Azathioprine; Cyclophosphamide; Cyclosporins; Deoxyguanosine; Dexamethasone; Disease Models | 1989 |
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Analysis of Variance; Azathioprine; Bone Marrow Transplantati | 1989 |
Therapy of chronic graft-v-host disease in a rat model.
Topics: Animals; Azathioprine; Cyclosporins; Disease Models, Animal; Drug Synergism; Graft vs Host Disease; | 1989 |
Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Leukemi | 1988 |
Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients.
Topics: Acute Kidney Injury; Adult; Azathioprine; beta 2-Microglobulin; Cardiopulmonary Bypass; Cyclosporins | 1987 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Bone Marrow; Bone Marrow Transplantation; Child | 1985 |
[Clinical picture of kidney transplantation. Surgical report].
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Dactinomycin; Gastrointestinal Hemorrhage; Graft vs Hos | 1968 |
Renal homotransplantation. The cytology of the urine sediment.
Topics: Adrenal Cortex Hormones; Azaserine; Azathioprine; Cytomegalovirus Infections; Dactinomycin; Graft vs | 1967 |
Proliferation of white blood cells in the blood of human renal allograft recipients. Lack of correlation with acute rejection episodes.
Topics: Adult; Autoradiography; Azathioprine; Cell Division; Child; DNA; Erythrocytes; Female; Graft Rejecti | 1972 |
Antilymphocyte globulin prepared by precipitation with Rivanol in the treatment of acute rejection following allogenic renal transplantation in the dog.
Topics: Acridines; Animals; Antilymphocyte Serum; Azathioprine; Chemical Precipitation; Creatinine; Dogs; Gr | 1972 |
Endocrine function of the pancreatic allograft.
Topics: Animals; Azathioprine; Blood Glucose; Dogs; Glucose Tolerance Test; Graft vs Host Disease; Hyperglyc | 1968 |
Wasting syndrome in thymectomized immature baboons (papio species) after infection with adenovirus type 12.
Topics: Adenoviridae; Alopecia; Animals; Antibody Formation; Azathioprine; Body Weight; Cobalt Isotopes; Com | 1967 |
New methods of treatment for renal allotransplants using the baboon as a primate experimental model.
Topics: Animals; Antibodies; Azathioprine; Cyclophosphamide; Female; Globulins; Graft vs Host Disease; Haplo | 1969 |
Radiation for immunosuppression in human organ transplantation. II. Clinical experience.
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Azathioprine; Blood; Cadaver; Child; Dogs; Extraco | 1971 |
Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis.
Topics: Adult; Animals; Azathioprine; Female; Graft vs Host Disease; Growth; Humans; Injections, Intravenous | 1969 |